Shareholders

In this section you can find an overview of shareholders holding at least 3% of Fagron shares, the number of shares held by the members of Fagron’s Board of Directors and the number of shares held by the members of Fagron’s Executive Leadership Team.

Shareholder structure

Article 11 of the articles of association of the company specifies that participations must be notified as soon as a threshold of 3%, 5% and any multiple of 5% has been passed.

The number of Fagron shares with voting rights is 73,228,904. The total number of voting rights (denominator) is 73,228,904.

* in relation to the notifications received from The Goldman Sachs Group, Inc. and NN Group N.V. please read the following document.

Situation on 15 March 2024, based on notifications received:

Number of shares

% of effective voting rights

The Goldman Sachs Group, Inc.*

13,209,148

18.04%

NN Group NV*

11,605,000

15.85%

AOC Pharma S.à r.l.

8,102,492

11.06%

Mawer Investment Management Ltd.

3,678,690

5.02%

FMR LLC

3,639,823

4.97%

Alychlo NV

3,641,933

4.97%

* in relation to the notifications received from The Goldman Sachs Group, Inc. and NN Group N.V. please read the following document.

The shareholding of Fagron’s Board of Directors as most recently updated per 25 March 2024 is presented in the table below.

Number of shares

Koen Hoffman 0
Rafael Padilla

101,111

Karin de Jong

17,500

Rob ten Hoedt 0
Els Vandecandelaere 0
Ann Desender 0
Neeraj Sharma 0
Klaus Röhrig

See the most recent transparency notification
from AOC Pharma S.á r.l.

The shareholding of Fagron’s Executive Leadership Team as most recently updated per 25 March 2024 is presented in the table below.

Number of shares

Rafael Padilla

101,111

Karin de Jong

17,500

Vera Bakker

350

Andrew Pulido

20,000

Geraldino Neder 0
Johan Verlinden

8,000

Maarten Pouw 0

Latest notifications

Shareholding declaration obligation (Transparancy declaration). For practical information and forms, please visit the website of FSMA: www.fsma.be

Mawer Investment Management Ltd. – Transparency notification (upward crossing)

Open

Openbaarmaking kennisgeving van AOC Pharma S.à r.l. – passering 10% drempel

Open

Disclosure notification from AOC Pharma S.à r.l. – passing 10% threshold

Open

BNP Paribas Asset Management SA – Transparency notification (downward crossing) 6 December 2023

Open